GI & Endoscopy

Michael Epstein, MD, is a gastroenterologist at Annapolis, Md.-based Digestive Disorders Associates.

Here are the five most popular gastroenterology and endoscopy stories for the week of April 2 to April 6, 2018.

Richard Panicco, DO, is a gastroenterologist at Washington, Pa.-based Southwest Gastroenterology Associates.

Research out of Solna, Sweden-based Karolinska Institutet claims to have found a link to irritable bowel syndrome in certain DNA variants.

Ferring Pharmaceuticals agreed to acquire Rebiotix for an unspecified sum.

Here are four gastroenterologists who made headlines this past week.

Perrigo and Dexcel Pharma Technologies launched Omeprazole Delayed Release Orally Disintegrating Tablets, an over-the-counter medication to treat heartburn.

Gastroenterologists are most likely to drive Toyotas, according to the Medscape Gastroenterologist Lifestyle Report 2018: Personal Happiness vs Work Burnout.

Memorial Hermann Cypress (Texas) Hospital's recently approved $25 million expansion will include an endoscopy suite for GI procedures, Chron reports.

Becker's ASC Review spoke with William Chey, MD, of Ritter Pharmaceuticals' medical advisory board, about the first treatment for lactose intolerance, the company's RP-G28. The treatment has not yet received FDA approval.